ArticleBMC pulmonary medicine2024

Validation of risk assessment scores in predicting venous thromboembolism in patients with lung cancer receiving immune checkpoint inhibitors.

Jiarui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.